Search Results 151-160 of 15537 for TNF

1. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Mayo Clinic

   Unstable biological therapy (e.g., TNF-α (anti-tumor necrosis factor), natalizumab, etc.), including significant changes in doses or switch of drug within 6 ...

2. Rhabdomyosarcoma - Doctors and departments - Mayo Clinic

   This rare soft tissue cancer affects children more often than adults. Treatment may include surgery, chemotherapy and radiation therapy.

3. Rhabdomyosarcoma - Doctors and departments - Mayo Clinic

   This rare soft tissue cancer affects children more often than adults. Treatment may include surgery, chemotherapy and radiation therapy.

4. Nonalcoholic fatty liver disease - Doctors and departments - Mayo Clinic

   Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

5. Uncovering the Signaling Events Underlying the Development and Progression of Pancreatic Cancer - Tumor Development, Immunology and Progression Laboratory - Mayo Clinic Research

   For example, the researchers found that macrophages can cause acinar-to-ductal metaplasia (ADM) by secreting inflammatory cytokines such as TNF and RANTES.

6. Uncovering the Signaling Events Underlying the Development and Progression of Pancreatic Cancer - Tumor Development, Immunology and Progression Laboratory - Mayo Clinic Research

   For example, the researchers found that macrophages can cause acinar-to-ductal metaplasia (ADM) by secreting inflammatory cytokines such as TNF and RANTES.

7. Nonalcoholic fatty liver disease - Doctors and departments - Mayo Clinic

   Mayo Clinic investigators are making new discoveries in the areas of cause, prevention and treatment of NAFLD . Their findings are helping to improve patient ...

8. Biomarker-guided CNI substitution in Kidney Transplantation Assessment - Mayo Clinic

   anti-Tumor necrosis factor(TNF) Monoclonal antibodies (mAb), or Belatacept, abatacept, Janus kinase inhibitors) 4. Transplant in which the kidney donor is ...

9. SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry - Mayo Clinic

   Patient must receive anti-TNF treatment within 2 months following enrollment into the registry. Patient is currently receiving immunosuppressant therapy for ...

10. Rilonacept in Subjects with Cardiac Sarcoidosis - Mayo Clinic

    Planned to initiate TNF-? antagonist therapy over the course of the study ... TNF inhibitors within 2-8 weeks of or 5 half-lives (etanercept within 2 ...